Cytokinetics Inc (CYTK)
Return on assets (ROA)
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net income (ttm) | US$ in thousands | -589,526 | -576,402 | -545,279 | -530,598 | -524,396 | -518,961 | -565,718 | -465,847 | -437,439 | -336,548 | -236,455 | -269,243 | -215,314 | -228,674 | -155,763 | -134,989 | -127,290 | -114,000 | -140,398 | -131,731 |
| Total assets | US$ in thousands | 1,401,670 | 1,436,060 | 1,523,790 | 808,082 | 824,316 | 740,614 | 779,899 | 889,815 | 1,014,780 | 1,075,960 | 771,717 | 856,253 | 841,319 | 827,539 | 564,302 | 577,062 | 533,803 | 474,112 | 232,495 | 256,582 |
| ROA | -42.06% | -40.14% | -35.78% | -65.66% | -63.62% | -70.07% | -72.54% | -52.35% | -43.11% | -31.28% | -30.64% | -31.44% | -25.59% | -27.63% | -27.60% | -23.39% | -23.85% | -24.04% | -60.39% | -51.34% |
December 31, 2024 calculation
ROA = Net income (ttm) ÷ Total assets
= $-589,526K ÷ $1,401,670K
= -42.06%
The return on assets (ROA) of Cytokinetics Inc has shown significant fluctuations over the past few years. The ROA has been consistently negative, indicating that the company is generating losses relative to its total assets.
The ROA started at a very low level in March 2020, at -51.34%, and experienced a sharp decline to -60.39% by June 2020. The metric improved slightly in the following quarters but remained negative, with values fluctuating around the -20% to -30% range throughout 2020 and 2021.
However, from March 2022 onwards, there was a noticeable deterioration in ROA, with values dropping to even lower levels, reaching -72.54% by June 2023. The ROA remained highly negative, with values hovering around -40% to -70% from 2023 to 2024.
The consistently negative ROA suggests that Cytokinetics Inc is struggling to effectively utilize its assets to generate profits. Investors and stakeholders may view this trend as concerning, as it indicates ongoing financial challenges for the company in terms of its operational efficiency and profitability.
Peer comparison
Dec 31, 2024